The Technical AnalystExchange: TAI Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Grape King Bio Ltd Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.64% TWD158.00
America/New_York / 3 mai 2024 @ 01:30
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 23 406 mill |
| EPS: | 9.73 |
| P/E: | 16.24 |
| Earnings Date: | May 08, 2024 |
| SharesOutstanding: | 148.14 mill |
| Avg Daily Volume: | 0.307 mill |
| RATING 2024-05-03 |
|---|
| A |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Sell | |
| P/E: | Neutral | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.88x |
| Company: PE 16.24 | sector: PE 18.55 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.35x |
| Company: PE 16.24 | industry: PE 11.99 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
TWD301.59 (90.88%) TWD143.59 |
| Date: 2024-05-04 |
| Expected Trading Range (DAY) |
|---|
|
TWD 155.79 - 160.21 ( +/- 1.40%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | TWD158.00 (0.64% ) |
| Volume | 0.261 mill |
| Avg. Vol. | 0.307 mill |
| % of Avg. Vol | 84.80 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 1707.TW
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
1707.TW
Grape King Bio Ltd produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy foods in Taiwan, China, and internationally. It operates through Multi-Level Marketing, Distributors, and Original Design Manufacturer/Original Equipment Manufacturer (ODM/OEM) segments. The company offers mushroom mycelium products, such as ganoderma lucidum, agaricus blazei, antrodia cinnamomea, cordyceps sinensis, and coriolus versicolor; probiotics, including enterococcus, bifidobacterium, lactobacillus, pediococcus, streptococcus, saccharomyces, and clostridium; and enzymes. It also provides OEM, ODM, formulation design, research and development, and raw material supply services. The company was founded in 1969 and is headquartered in Taoyuan City, Taiwan.